Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer
Clinical trial NCT07391345 · RECRUITING
Trial details
- NCT number
- NCT07391345
- Sponsor
- Viktoras Rudzianskas
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2029-09-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.